Bhatt DL - Search Results

1

Variability in platelet responsiveness to clopidogrel among 544 individuals.

Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Serebruany VL, et al. Among authors: bhatt dl. J Am Coll Cardiol. 2005 Jan 18;45(2):246-51. doi: 10.1016/j.jacc.2004.09.067. J Am Coll Cardiol. 2005. PMID: 15653023

2

Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ. Bhatt DL, et al. J Am Coll Cardiol. 2000 Mar 15;35(4):922-8. doi: 10.1016/s0735-1097(99)00650-6. J Am Coll Cardiol. 2000. PMID: 10732889

3

The benefit of abciximab in percutaneous coronary revascularization is not device-specific.

Bhatt DL, Lincoff AM, Califf RM, Simoons ML, Tcheng JE, Brener SJ, Wolski KE, Topol EJ. Bhatt DL, et al. Am J Cardiol. 2000 May 1;85(9):1060-4. doi: 10.1016/s0002-9149(00)00696-2. Am J Cardiol. 2000. PMID: 10781752

4

Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators.

Bhatt DL, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Bhatt DL, et al. Am Heart J. 2000 Jul;140(1):67-73. doi: 10.1067/mhj.2000.108239. Am Heart J. 2000. PMID: 10874265 Clinical Trial.

5

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery.

Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Bhatt DL, et al. Circulation. 2001 Jan 23;103(3):363-8. doi: 10.1161/01.cir.103.3.363. Circulation. 2001. PMID: 11157686 Clinical Trial.

6

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.

Chew DP, Bhatt DL, Robbins MA, Mukherjee D, Roffi M, Schneider JP, Topol EJ, Ellis SG. Chew DP, et al. Among authors: bhatt dl. Am J Cardiol. 2001 Sep 15;88(6):672-4. doi: 10.1016/s0002-9149(01)01813-6. Am J Cardiol. 2001. PMID: 11564394 No abstract available.

7

Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting.

Bhatt DL, Kapadia SR, Bajzer CT, Chew DP, Ziada KM, Mukherjee D, Roffi M, Topol EJ, Yadav JS. Bhatt DL, et al. J Invasive Cardiol. 2001 Dec;13(12):767-71. J Invasive Cardiol. 2001. PMID: 11731685

8

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting.

Bhatt DL, Bertrand ME, Berger PB, L'Allier PL, Moussa I, Moses JW, Dangas G, Taniuchi M, Lasala JM, Holmes DR, Ellis SG, Topol EJ. Bhatt DL, et al. J Am Coll Cardiol. 2002 Jan 2;39(1):9-14. doi: 10.1016/s0735-1097(01)01713-2. J Am Coll Cardiol. 2002. PMID: 11755280

9

Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction.

Chan AW, Chew DP, Bhatt DL, Moliterno DJ, Topol EJ, Ellis SG. Chan AW, et al. Among authors: bhatt dl. Am J Cardiol. 2002 Jan 15;89(2):132-6. doi: 10.1016/s0002-9149(01)02188-9. Am J Cardiol. 2002. PMID: 11792330

10

The CURE trial: using clopidogrel in acute coronary syndromes without ST-segment elevation.

Gerschutz GP, Bhatt DL. Gerschutz GP, et al. Among authors: bhatt dl. Cleve Clin J Med. 2002 May;69(5):377-8, 380, 382 passim. doi: 10.3949/ccjm.69.5.377. Cleve Clin J Med. 2002. PMID: 12022381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results